Semaglutide 2.4 mg: what it costs
Step 5 of the semaglutide ladder, around weeks 17+. 6 providers charge the same here as at the starting dose — the rest may not.
Updated 2026-09-18 · every price checked by hand
2.4 mg is where a lot of programmes quietly start charging you more, and almost nobody warns you before you sign up.
2.4 mg is step 5 of 5 on the semaglutide ladder, reached around weeks 17+. The maintenance dose for weight management, and the one behind the figure most people have read.
It is also the point where pricing starts to matter. On a programme that charges by dose, your bill climbs exactly as the treatment begins working. On a flat-rate programme, 2.4 mg costs what the starting dose cost — and over a full titration that difference is worth more than almost any advertised discount.
The rung where the bill changes
Dose-tiered pricing means your cost rises as the treatment starts working. We track which programmes hold a single price across the whole ladder and which do not, because over a full titration that is worth more than any advertised discount.
What 2.4 mg is for
2.4 mg is the semaglutide dose behind the figure everyone quotes: roughly 14.9% average body-weight loss over 68 weeks in STEP-1. It is the maintenance target for weight management, and for many people the end of the ladder. Worth holding onto, though: that 14.9% is an average from a controlled trial with structured support, and about 60% of weight lost is regained within a year of stopping — so the more useful question at this rung is what the long-term plan looks like, not how fast you got here.
The evidence. In STEP-1, adults on 2.4 mg lost an average of about 14.9% of body weight over 68 weeks.
This is the target for many people, but not a requirement. Settling lower and tolerating it beats reaching 2.4 mg and stopping.
What 2.4 mg costs
6 of the providers we track hold a single price at every dose, so 2.4 mg costs the same as the starting dose. They are listed first below because at this rung that is the whole ballgame.
| Provider | Price at 2.4 mg | Per year | Score |
|---|---|---|---|
| Coreage Rx | $139 | $1,668 | 4.5 |
| Trimi | $99 | $1,188 | 4.6 |
| Mochi Health | $178 | $2,136 | 3.6 |
| PlexusDx | $189 | $2,268 | 4.4 |
| Eden | $198 | $2,376 | 3.1 |
| Remedy Meds | $299 | $3,588 | 3.5 |
Cheapest flat-rate option at 2.4 mg: Trimi at $99 a month, which is what it charges at every other rung too.
The remaining 10 providers either price by dose or do not publish a flat-rate commitment. Their quoted figures start at $85 a month, but that is the starting-dose price — ask specifically what 2.4 mg will cost before you assume it holds.
The question to ask before you start. "What will I be charged when I reach 2.4 mg?" If the answer is not the same number you were quoted at the start, you are on a tiered programme and should budget for the higher figure rather than the advertised one.
Do you need to go higher than 2.4 mg?
2.4 mg is the top of the ladder, so the question here is the opposite one: whether you need to stay this high. Some people step back down to a lower maintenance dose once they have reached their goal. That is a conversation for your prescriber.
What happens when I reach 2.4 mg?
For most people it becomes the ongoing maintenance dose rather than a finish line. Clinicians increasingly treat GLP-1 therapy the way they treat blood-pressure medication — something you stay on — which makes the monthly price a multi-year decision rather than a three-month one.
Before you spend anything: approved oral GLP-1s start at $149 a month and Medicare drops to $50 in July 2026. Both undercut a large part of this market, and neither is compounded.
Read next
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure
